Is FEMY or AMIX more profitable?

Autonomix Medical has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Autonomix Medical's return on equity of -239.36% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -521.97% -258.08% -73.72% Autonomix Medical N/A -239.36% -192.46%

Do analysts prefer AMIX or PFSA?

Autonomix Medical currently has a consensus price target of $42.00, suggesting a potential upside of 718.71%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Autonomix Medical is more favorable than Profusa. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Profusa 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AMIX or PFSA more profitable?

Profusa's return on equity of 0.00% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% Profusa N/A N/A -1,348.07%

Does the media favor AMIX or PFSA?

In the previous week, Autonomix Medical had 4 more articles in the media than Profusa. MarketBeat recorded 7 mentions for Autonomix Medical and 3 mentions for Profusa. Autonomix Medical's average media sentiment score of 0.86 beat Profusa's score of 0.30 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Profusa 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer AMIX or OSRH?

Autonomix Medical presently has a consensus target price of $42.00, indicating a potential upside of 718.71%. Given Autonomix Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AMIX or OSRH more profitable?

Autonomix Medical has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% OSR -363.26% -7.24% -5.41%

Is AMIX or SURG more profitable?

Autonomix Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. SurgePays' return on equity of 0.00% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% SurgePays -64.91% N/A -310.16%

Autonomix Medical (AMIX) Competitors

$5.13 -0.06 (-1.16%)

Closing price 04:00 PM Eastern

Extended Trading

$5.23 +0.10 (+1.95%)

As of 07:30 PM Eastern

Compare

AMIX vs. FEMY, PFSA, OSRH, SURG, and CODX

Should you buy Autonomix Medical stock or one of its competitors? MarketBeat compares Autonomix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Autonomix Medical include Femasys (FEMY), Profusa (PFSA), OSR (OSRH), SurgePays (SURG), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry.

How does Autonomix Medical compare to Femasys?

Femasys (NASDAQ:FEMY) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Autonomix Medical has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Autonomix Medical's return on equity of -239.36% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Autonomix Medical	N/A	-239.36%	-192.46%

Autonomix Medical has lower revenue, but higher earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	4.71	-$18.63M	-$5.40	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$74.58	N/A

Femasys has a beta of -2.13, meaning that its share price is 313% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.32, meaning that its share price is 232% less volatile than the broader market.

In the previous week, Autonomix Medical had 6 more articles in the media than Femasys. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for Femasys. Femasys' average media sentiment score of 1.87 beat Autonomix Medical's score of 0.86 indicating that Femasys is being referred to more favorably in the media.

Company	Overall Sentiment
Femasys	Very Positive
Autonomix Medical	Positive

65.3% of Femasys shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 7.8% of Femasys shares are owned by company insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Femasys currently has a consensus target price of $106.67, suggesting a potential upside of 2,887.86%. Autonomix Medical has a consensus target price of $42.00, suggesting a potential upside of 718.71%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Autonomix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Femasys beats Autonomix Medical on 9 of the 14 factors compared between the two stocks.

How does Autonomix Medical compare to Profusa?

Autonomix Medical (NASDAQ:AMIX) and Profusa (NASDAQ:PFSA) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Autonomix Medical currently has a consensus price target of $42.00, suggesting a potential upside of 718.71%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Autonomix Medical is more favorable than Profusa.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Profusa	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Autonomix Medical had 4 more articles in the media than Profusa. MarketBeat recorded 7 mentions for Autonomix Medical and 3 mentions for Profusa. Autonomix Medical's average media sentiment score of 0.86 beat Profusa's score of 0.30 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Profusa	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 9.8% of Profusa shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 0.8% of Profusa shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Autonomix Medical has a beta of -1.32, suggesting that its share price is 232% less volatile than the broader market. Comparatively, Profusa has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

Profusa's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Profusa	N/A	N/A	-1,348.07%

Autonomix Medical has higher earnings, but lower revenue than Profusa. Autonomix Medical is trading at a lower price-to-earnings ratio than Profusa, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$74.58	N/A
Profusa	$100K	3.59	-$35.82M	-$169.72	N/A

Summary

Autonomix Medical beats Profusa on 10 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to OSR?

Autonomix Medical (NASDAQ:AMIX) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Autonomix Medical had 6 more articles in the media than OSR. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for OSR. OSR's average media sentiment score of 0.94 beat Autonomix Medical's score of 0.86 indicating that OSR is being referred to more favorably in the news media.

Company	Overall Sentiment
Autonomix Medical	Positive
OSR	Positive

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by insiders. Comparatively, 36.8% of OSR shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Autonomix Medical has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
OSR	-363.26%	-7.24%	-5.41%

Autonomix Medical has higher earnings, but lower revenue than OSR. OSR is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$74.58	N/A
OSR	$2.91M	5.07	-$27.06M	-$0.33	N/A

Autonomix Medical presently has a consensus target price of $42.00, indicating a potential upside of 718.71%. Given Autonomix Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Autonomix Medical has a beta of -1.32, suggesting that its share price is 232% less volatile than the broader market. Comparatively, OSR has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

Summary

OSR beats Autonomix Medical on 8 of the 14 factors compared between the two stocks.

How does Autonomix Medical compare to SurgePays?

Autonomix Medical (NASDAQ:AMIX) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Autonomix Medical has a beta of -1.32, indicating that its stock price is 232% less volatile than the broader market. Comparatively, SurgePays has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

Autonomix Medical has higher earnings, but lower revenue than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$74.58	N/A
SurgePays	$56.96M	0.14	-$36.07M	-$1.94	N/A

Autonomix Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. SurgePays' return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
SurgePays	-64.91%	N/A	-310.16%

Autonomix Medical currently has a consensus price target of $42.00, indicating a potential upside of 718.71%. SurgePays has a consensus price target of $3.50, indicating a potential upside of 975.27%. Given SurgePays' higher probable upside, analysts clearly believe SurgePays is more favorable than Autonomix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 29.1% of SurgePays shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Autonomix Medical had 6 more articles in the media than SurgePays. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for SurgePays. SurgePays' average media sentiment score of 1.87 beat Autonomix Medical's score of 0.86 indicating that SurgePays is being referred to more favorably in the news media.

Company	Overall Sentiment
Autonomix Medical	Positive
SurgePays	Very Positive

Summary

SurgePays beats Autonomix Medical on 7 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Co-Diagnostics?

Autonomix Medical (NASDAQ:AMIX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

In the previous week, Autonomix Medical had 6 more articles in the media than Co-Diagnostics. MarketBeat recorded 7 mentions for Autonomix Medical and 1 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.94 beat Autonomix Medical's score of 0.86 indicating that Co-Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Autonomix Medical	Positive
Co-Diagnostics	Positive

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Autonomix Medical has higher earnings, but lower revenue than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$74.58	N/A
Co-Diagnostics	$620K	14.82	-$46.90M	-$15.77	N/A

Autonomix Medical has a beta of -1.32, suggesting that its stock price is 232% less volatile than the broader market. Comparatively, Co-Diagnostics has a beta of 2.84, suggesting that its stock price is 184% more volatile than the broader market.

Autonomix Medical currently has a consensus price target of $42.00, indicating a potential upside of 718.71%. Co-Diagnostics has a consensus price target of $67.50, indicating a potential upside of 2,610.84%. Given Co-Diagnostics' higher possible upside, analysts plainly believe Co-Diagnostics is more favorable than Autonomix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Autonomix Medical has a net margin of 0.00% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%

Summary

Co-Diagnostics beats Autonomix Medical on 8 of the 12 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMIX vs. The Competition

Export

Metric	Autonomix Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.82M	$7.41B	$6.77B	$12.66B
Dividend Yield	N/A	1.31%	2.68%	8.42%
P/E Ratio	N/A	50.74	27.12	24.37
Price / Sales	N/A	47.41	527.71	93.32
Price / Cash	N/A	26.31	48.59	59.39
Price / Book	0.47	7.21	10.82	6.32
Net Income	-$16.72M	$162.30M	$3.59B	$331.55M
7 Day Performance	-19.78%	0.64%	-1.21%	0.15%
1 Month Performance	-38.62%	-0.32%	3.13%	-0.68%
1 Year Performance	-82.80%	8.94%	29.12%	20.73%

Autonomix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMIX Autonomix Medical	3.5367 of 5 stars	$5.13 -1.2%	$42.00 +718.7%	-82.7%	$2.82M	N/A	N/A	1	News Coverage
FEMY Femasys	2.0869 of 5 stars	$3.96 +2.3%	$106.67 +2,593.6%	-80.8%	$11.96M	$2.29M	N/A	30	Positive News
PFSA Profusa	0.1413 of 5 stars	$2.40 -14.6%	N/A	N/A	$11.18M	$100K	N/A	2	News Coverage Short Interest Increase Gap Down High Trading Volume
OSRH OSR	0.8092 of 5 stars	$0.31 -2.0%	N/A	-68.2%	$10.80M	$2.91M	N/A	N/A	Gap Up
SURG SurgePays	4.3801 of 5 stars	$0.40 -2.2%	$3.50 +772.8%	-88.5%	$10.07M	$56.96M	N/A	40	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMIX) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Autonomix Medical (AMIX) Competitors

AMIX vs. FEMY, PFSA, OSRH, SURG, and CODX

How does Autonomix Medical compare to Femasys?

Summary

How does Autonomix Medical compare to Profusa?

Summary

How does Autonomix Medical compare to OSR?

Summary

How does Autonomix Medical compare to SurgePays?

Summary

How does Autonomix Medical compare to Co-Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Autonomix Medical (AMIX) Competitors

AMIX vs. FEMY, PFSA, OSRH, SURG, and CODX

How does Autonomix Medical compare to Femasys?

Is FEMY or AMIX more profitable?

Which has better earnings and valuation, FEMY or AMIX?

Which has more volatility & risk, FEMY or AMIX?

Does the media prefer FEMY or AMIX?

Do institutionals and insiders have more ownership in FEMY or AMIX?

Do analysts rate FEMY or AMIX?

Summary

How does Autonomix Medical compare to Profusa?

Do analysts prefer AMIX or PFSA?

Does the media favor AMIX or PFSA?

Do institutionals & insiders hold more shares of AMIX or PFSA?

Which has more risk & volatility, AMIX or PFSA?

Is AMIX or PFSA more profitable?

Which has preferable valuation & earnings, AMIX or PFSA?

Summary

How does Autonomix Medical compare to OSR?

Does the media favor AMIX or OSRH?

Do institutionals and insiders believe in AMIX or OSRH?

Is AMIX or OSRH more profitable?

Which has better valuation & earnings, AMIX or OSRH?

Do analysts prefer AMIX or OSRH?

Which has more risk and volatility, AMIX or OSRH?

Summary

How does Autonomix Medical compare to SurgePays?

Which has more risk and volatility, AMIX or SURG?

Which has better valuation and earnings, AMIX or SURG?

Is AMIX or SURG more profitable?

Do analysts recommend AMIX or SURG?

Do insiders & institutionals believe in AMIX or SURG?

Does the media favor AMIX or SURG?

Summary

How does Autonomix Medical compare to Co-Diagnostics?

Does the media favor AMIX or CODX?

Do institutionals & insiders believe in AMIX or CODX?

Which has higher valuation and earnings, AMIX or CODX?

Which has more volatility and risk, AMIX or CODX?

Do analysts rate AMIX or CODX?

Is AMIX or CODX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools